These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6685108)

  • 81. The clearance of a tracer dose of cholic acid in liver cirrhosis.
    Borel GA; Magnenat P
    Helv Med Acta; 1973 Sep; 37(2):129-35. PubMed ID: 4748921
    [No Abstract]   [Full Text] [Related]  

  • 82. [Evaluation of the portosystemic shunt by a new radioisotope technic in hepatic cirrhosis].
    Schuller A; Jelavic D; García de la Fuente A; Pozuelo A; Valdivieso L; Pérez Modrego S; Lasa D; Gálvez y Herránz P
    Rev Clin Esp; 1973 Jun; 129(6):539-44. PubMed ID: 4727646
    [No Abstract]   [Full Text] [Related]  

  • 83. [Vitamin A transport in the blood: retinol-binding serum protein and its biological role].
    Natanson AO; Kon' IIa
    Vopr Pitan; 1979; (3):3-12. PubMed ID: 111419
    [No Abstract]   [Full Text] [Related]  

  • 84. Depressed plasma Vitamin A and retinol-binding protein in cystic fibrosis correlations with zinc deficiency.
    Navarro J; Desquilbet N
    Am J Clin Nutr; 1981 Jul; 34(7):1439-40. PubMed ID: 7196148
    [No Abstract]   [Full Text] [Related]  

  • 85. [The diagnostic value of retinol-binding protein (RBP) in serum in patients with liver disease].
    Kindler U
    Dtsch Med Wochenschr; 1972 Nov; 97(47):1821-3. PubMed ID: 4629195
    [No Abstract]   [Full Text] [Related]  

  • 86. [Zinc deficiency and the severity of hepatic cirrhosis].
    Ortuño JA; Garrido G; Cubillo P; Alfonso V; Aznar J; Berenguer J
    Med Clin (Barc); 1987 Jun; 89(3):99-103. PubMed ID: 3626657
    [No Abstract]   [Full Text] [Related]  

  • 87. Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis.
    Yoshida Y; Higashi T; Nouso K; Nakatsukasa H; Nakamura SI; Watanabe A; Tsuji T
    Acta Med Okayama; 2001 Dec; 55(6):349-55. PubMed ID: 11779097
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Disposition of a flow-limited drug (lidocaine) and a metabolic capacity-limited drug (theophylline) in liver cirrhosis.
    Colli A; Buccino G; Cocciolo M; Parravicini R; Scaltrini G
    Clin Pharmacol Ther; 1988 Dec; 44(6):642-9. PubMed ID: 3197365
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Curve of plasma disappearance of bromosulfophthalein after a single injection. Control of cirrhosis patients after elective portosystemic derivation].
    Zotti S; Turrin M; Gerunda G; Maffei Faccioli A; Ghidini O
    Minerva Chir; 1984 Jun; 39(11):887-96. PubMed ID: 6483219
    [No Abstract]   [Full Text] [Related]  

  • 90. Skin disorders and vitamin A metabolism disturbances in chronic dialysis patients: the role of zinc, retinol-binding protein, retinol and retinoic acid.
    Delacoux E; Evstigneeff T; Leclercq M; Rettori MC; Delons S; Naret C; Blanchet-Bardon C
    Clin Chim Acta; 1984 Mar; 137(3):283-9. PubMed ID: 6538120
    [TBL] [Abstract][Full Text] [Related]  

  • 91. I-131 studies of the liver and portal circulation.
    Rozenbilds JG; Bennett RC
    Aust N Z J Surg; 1967 Feb; 36(3):234-7. PubMed ID: 5227487
    [No Abstract]   [Full Text] [Related]  

  • 92. The interaction of vitamin A and zinc: implications for human nutrition.
    Solomons NW; Russell RM
    Am J Clin Nutr; 1980 Sep; 33(9):2031-40. PubMed ID: 6774607
    [No Abstract]   [Full Text] [Related]  

  • 93. [The partial portosystemic shunting and its hemodynamic consequences].
    Shalimov AA; Kalita NIa; Kotenko OG
    Klin Khir; 2000 May; (5):5-7. PubMed ID: 11288249
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Incidence of cholelithiasis among patients with cirrhosis and portal hypertension.
    Steinberg HV; Beckett WW; Chezmar JL; Torres WE; Murphy FB; Bernardino ME
    Gastrointest Radiol; 1988 Oct; 13(4):347-50. PubMed ID: 3169482
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Changes of zinc metabolism in liver cirrhosis with and without encephalopathy].
    Santiago Corchado M; Ribas Ozonas B; Santos Ruiz A; Ortiz Vázquez J
    Rev Clin Esp; 1968 Jul; 110(2):109-14. PubMed ID: 5735082
    [No Abstract]   [Full Text] [Related]  

  • 96. Lack of increase in insulin resistance after portosystemic surgical shunt in patients with cirrhosis.
    Cavallo-Perin P; Bruno A; Nuccio P; Dall'omo AM; Pagano G; Robecchi A
    N Engl J Med; 1985 Jun; 312(26):1709-10. PubMed ID: 4000220
    [No Abstract]   [Full Text] [Related]  

  • 97. [Zinc values in the liver and urine in liver cirrhosis].
    Kallai L; Keler-Bacoka M; Stojanovski-Bubanj A; Korsić M; Knezević S; Hadzić N
    Schweiz Med Wochenschr; 1971 May; 101(18):643-6. PubMed ID: 5577380
    [No Abstract]   [Full Text] [Related]  

  • 98. Acquired dyschromatopsia in vitamin A deficiency.
    Bronte-Stewart J; Foulds WS
    Mod Probl Ophthalmol; 1972; 11():168-73. PubMed ID: 4132369
    [No Abstract]   [Full Text] [Related]  

  • 99. Acquired zinc deficiency in alcoholic liver cirrhosis: report of two cases.
    Weismann K; Høyer H; Christensen E
    Acta Derm Venereol; 1980; 60(5):447-9. PubMed ID: 6162323
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Portal hypertension without liver cirrhosis in chronic vitamin A intoxication].
    Kistler HJ; Plüer S; Dickenmann W; Pirozynski W
    Schweiz Med Wochenschr; 1977 Jun; 107(24):825-32. PubMed ID: 267312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.